Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science

Y Xiang, Z Guo, P Zhu, J Chen, Y Huang - Cancer medicine, 2019 - Wiley Online Library
Traditional Chinese medicine (TCM) has been practiced for thousands of years and at the
present time is widely accepted as an alternative treatment for cancer. In this review, we …

Role of silymarin in cancer treatment: facts, hypotheses, and questions

T Koltai, L Fliegel - Journal of Evidence-Based Integrative …, 2022 - journals.sagepub.com
The flavonoid silymarin extracted from the seeds of Sylibum marianum is a mixture of 6
flavolignan isomers. The 3 more important isomers are silybin (or silibinin), silydianin, and …

Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer–A comprehensive review

N Polachi, G Bai, T Li, Y Chu, X Wang, S Li… - European journal of …, 2016 - Elsevier
Silibinin, a natural flavanone, derived from the milk thistle plant (Silybum marianum), was
illustrated for several medicinal uses such as liver-protective, anti-oxidant, anti-cancer, anti …

[HTML][HTML] Anticancer potential of silibinin loaded polymeric nanoparticles against breast cancer cells: insight into the apoptotic genes targets

A Pourgholi, M Dadashpour, A Mousapour… - Asian Pacific Journal …, 2021 - ncbi.nlm.nih.gov
Silibinin (SIL) is a natural polyphenolic flavonoid with multiple biological and anti-cancer
features. However, the complex hydrophobic nature and inadequate bioavailability of SIL …

Breast cancer stem cells: A review of their characteristics and the agents that affect them

NL Shan, Y Shin, G Yang, P Furmanski… - Molecular …, 2021 - Wiley Online Library
The evolving concept that cancer stem cells (CSCs) are the driving element in cancer
development, evolution and heterogeneity, has overridden the previous model of a tumor …

Optimized dosing schedule based on circadian dynamics of mouse breast cancer stem cells improves the antitumor effects of aldehyde dehydrogenase inhibitor

N Matsunaga, T Ogino, Y Hara, T Tanaka, S Koyanagi… - Cancer research, 2018 - AACR
Although malignant phenotypes of triple-negative breast cancer (TNBC) are subject to
circadian alterations, the role of cancer stem cells (CSC) in defining this circadian change …

Current report of natural product development against breast cancer stem cells

A Hermawan, H Putri - The international journal of biochemistry & cell …, 2018 - Elsevier
Chemotherapeutic agents are commonly used as neoadjuvant for breast cancer therapy.
However, there is evidence of treatment failure for most of patients due to acquired …

Bioinformatics and in vitro studies reveal the importance of p53, PPARG and notch signaling pathway in inhibition of breast cancer stem cells by hesperetin

A Hermawan, M Ikawati, A Khumaira… - Advanced …, 2020 - pmc.ncbi.nlm.nih.gov
Purpose: The failure of chemotherapy in breast cancer is caused by breast cancer stem cells
(BCSCs), a minor population of cells in bulk mammary tumors. Previously, hesperetin, a …

Identification of key genes of hesperidin in inhibition of breast cancer stem cells by functional network analysis

A Hermawan, A Khumaira, M Ikawati, H Putri… - … Biology and Chemistry, 2021 - Elsevier
Breast cancer therapy with classical chemotherapy is unable to eradicate breast cancer
stem cells (BCSCs). Loss of p53 function causes growth and differentiation in cancer stem …

[PDF][PDF] Silibinin in cancer therapy: A promising prospect

P Tiwari, K Mishra - Cancer Res Front, 2015 - researchgate.net
The potential anti-cancer properties of natural plant compounds have elicited widespread
interest in recent times since it is believed that they can substantially contribute to the …